FDA

Ecstasy ingredient MDMA granted ‘Breakthrough Therapy Designation’ status

Ecstasy ingredient MDMA granted ‘Breakthrough Therapy Designation’ status

Supporting the need for medical research on psychedelic substances, the U.S. Food & Drug Administration (FDA) recently granted the ecstasy ingredient MDMA "Breakthrough Therapy Designation" status.

The term of “Breakthrough Therapy Designation” means that the federal agency will expedite the development as well as review of the ecstasy drug. This status is granted to those substances that are projected to treat a grave or life-threatening health condition.

Tags: 

FDA approves Pfizer's new blood cancer drug

FDA approves Pfizer's new blood cancer drug

The U.S. Food & Drug Administration (FDA) has given its approval for a new Pfizer medicine for use against a rare form of blood cancer, albeit with a boxed warning.

The FDA said Pfizer’s Besponsa medicine can be used to cure patients suffering a kind of advanced acute lymphoblastic leukemia, a rare kind of blood cancer. By this stage, life expectancy for the patient declines to a very low level.

Tags: 

FDA approves new drug to treat all forms of hepatitis C

FDA approves new drug to treat all forms of hepatitis C

The U.S. Food & Drug Administration (FDA) has finally approved the first drug to treat all forms of hepatitis C for patients who weren’t cured by prior treatment.

The just approved pill combination known as Mavyret (glecaprevir and pibrentasvir) is from AbbVie Inc. Mavyret joins a couple of other AbbVie hepatitis C drugs that are already of the market.

The approval of the new drug is for all sorts of hepatitis C. Its approval will provide doctors and patients with more options. Insurers will get more leverage to mangle discounts out of firms to cover the pricey drugs.

Tags: 

FDA preparing to cut nicotine levels in cigarettes

FDA preparing to cut nicotine levels in cigarettes

In yet another effort to fight back addition to smoking, the U.S. Food & Drug Administration (FDA) is aiming to lower nicotine levels in cigarettes.

On Friday, FDA Chief Scott Gottlieb directed staff to develop new regulations on levels of nicotine in smoking products. The federal government has proposed cutting levels of nicotine in cigarettes so that these products become less addictive.

Addressing agency staff, Gottlieb said, “A renewed focus on nicotine can help us to achieve a world where cigarettes no longer addict future generations of our kids.”

Tags: 

Texas coffee recalled because of its Viagra-like ingredients

Texas coffee recalled because of its Viagra-like ingredients

Bestherbs Coffee LLC in North Texas has issued a voluntarily recall for its traditional herbal coffee because it contains an ingredient similar to Viagra, the U.S. Food & Drug Administration (FDA) confirmed Thursday.

The coffee company also confirmed that it has been recalling its “New of Kopi Jantan Tradisional Herbs Coffee” because a Viagra-like ingredient has been giving customers more than their normal boost of energy.

Tags: 

FDA approves new drug for ALS treatment

FDA approves new drug for ALS treatment

The U.S. Food & Drug Administration (FDA) has finally given its approval for a new drug for the treatment of amyotrophic lateral sclerosis (ALS).

The federal agency announced that Radicava, which is also known as edaravone, has been approved for the treatment of ALS in the United States. The only other drug tthat is available iin the nation specifically for the treatment of condition is riluzole.

Tags: 

FDA approves Radicava for Amyotrophic lateral sclerosis (ALS)

FDA approves Radicava for Amyotrophic lateral sclerosis (ALS)

The U.S. Food and Drug Administration has approved a drug for treatment of rare paralyzing disease Amyotrophic lateral sclerosis (ALS). ALS impacts nearly 12,000 to 15,000 Americans as per CDC data. The drug Radicava has been developed in Japan. The drug has been approved in Japan for treatment of stroke. Radicava or edaravone is the first drug to be approved for ALS treatment since Rilutek was approved by FDA in 1995.

Tags: 

Brineura Wins FDA Approval for Type of Batten Disease

Brineura Wins FDA Approval for Type of Batten Disease

The U.S. FDA has approved Brineura for treatment of a rare type of Batten Disease. One type of neuronal ceroid lipofuscinoses (collectively termed as Batten Disease), primarily affects the nervous system at an early age. The symptoms include language delays, ataxia and epilepsy. The symptoms usually show up between age 2 and 4 years and in certain cases, the disease even leads to vision loss.

Tags: 

FDA issues warning after finding inconsistent levels of belladonna in teething products

FDA issues warning after finding inconsistent levels of belladonna in teething products

After finding inconsistent amounts of a toxic substance called belladonna in certain homeopathic teething tablets, the U.S. Food & Drug Administration (FDA) recommend parents and caregivers not give these tablets to babies.

Homeopathic teething tablets containing belladonna are widely given to babies when they are growing their first teeth as these tablets provide temporary relief. These products have been around in the nation since the early 1900s.

Tags: 

Sabra recalls Hummus products due to Listeria risk

Sabra recalls Hummus products due to Listeria risk

The U.S. Food & Drug Administration has confirmed that Sabra Dipping Co. has issued a voluntary recall for some of its hummus products after food inspectors detected potential listeria contamination risk.

Listeria infection causes serious and sometimes fatal infections, particularly in kids, old people, and others with undermined immune systems. The long list of symptoms includes muscle aches, stiffness, fever, diarrhea and abdominal pain.

Pages

Subscribe to RSS - FDA